Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01540370 · ClinicalTrials.gov registry record
Study Comparing Quantitative Assessments in Open-angle Glaucoma (OAG) and/or Ocular Hypertension (OHT)
A clinical trial, sponsored by Allergan.
- Completed
- Registry status
- 102
- Enrollment target
NCT01540370 is a clinical trial that has completed, run by Allergan. The registered enrollment target is 102 participants.
The verdict
NCT01540370 has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- 102 participants
- Enrollment target
Study Summary
This study will evaluate assessments from the Goniometric Lens compared with those from anterior segment imaging in patients with open-angle glaucoma (OAG) and/or ocular hypertension (OHT).
Interventions
- OTHER No Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2012-02 |
| Est. Completion | 2012-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01540370
The ClinicalTrials.gov registry entry for NCT01540370 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No Treatment is the first listed.
NCT01540370 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01540370 about?
NCT01540370 is a clinical study titled "Study Comparing Quantitative Assessments in Open-angle Glaucoma (OAG) and/or Ocular Hypertension (OHT)". This study will evaluate assessments from the Goniometric Lens compared with those from anterior segment imaging in patients with open-angle glaucoma (OAG) and/or ocular hypertension (OHT).
What is the current status of trial NCT01540370?
This trial is currently completed. The enrollment target is 102 participants. The study started on 2012-02. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01540370?
The interventions under investigation include: No Treatment (OTHER).
Who is sponsoring clinical trial NCT01540370?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.